Antidepressant and Anxiolytic Effect of Tramadol as Compared to Imipramine, in Acute and Chronic Dosage in Rats
Antidepressant and Anxiolytic Effects of Tramadol & Imipramine
Keywords:Depressive Disorder (Major), Antidepressive Agents, Anti-Anxiety Agents, Tramadol, Imipramine
Objective: To assess the anti-depressant and anxiolytic effect of tramadol as compared to imipramine (approved antidepressant) in acute and chronic doses in rats.
Methodology: This observational experimental animal study was carried out from December 2020 to February 2021 at Liaquat University of Medical and Health Sciences (LUMHS) Jamshoro in collaboration with Agricultural University, Tandojam. Forty- eight healthy male rats housed at Animal House Sindh, Agricultural University, Tandojam after due approval from institutional ethical review board. The 48 rats were categorized into 3 equal groups of 16 each: Group A for Normal saline (0.9% NaCl) 15ml/kg, Group B for Imipramine 15 mg/kg and Group C for Tramadol 15 mg/kg. Each group was further subdivided into two groups namely acute A1, B1, C1 and chronic A2, B2, C2 and evaluated for anti-depressant and anxiety activity using forced swim test and elevated plus maze test. The data obtained was analyzed using SPSS. 22.0.
Results: Tramadol acted to significantly reduce the mean duration of immobility as compared to the control (P<0.001). Resolution of immobility due to tramadol was insignificant when compared to imipramine. Likewise, the swimming periods in the tramadol and imipramine groups were significantly longer than the control group (<0.001), but almost equal in both tramadol and imipramine groups, showcasing that tramadol has antidepressant activity at par with imipramine (p value >0.05).
Conclusion: Tramadol exhibits significant acute and chronic antidepressant and anxiolytic effects in rats when compared to imipramine and controls.
How to Cite
Copyright (c) 2022 Fizza Soomro, Nasreen Kazi, Aatir Hanif Rajput, Sadat Memon
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
You are free to:
- Share — copy and redistribute the material in any medium or format
- Adapt — remix, transform, and build upon the material
- The licensor cannot revoke these freedoms as long as you follow the license terms.
Under the following terms:
Attribution — You must give appropriate credit, provide a link to the license, and indicate if changes were made. You may do so in any reasonable manner, but not in any way that suggests the licensor endorses you or your use.
Non Commercial — You may not use the material for commercial purposes.
No additional restrictions — You may not apply legal terms or technological measures that legally restrict others from doing anything the license permits.